MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on ...
Advancing a Safe and Effective Alternative for Neuropathic Pain MIRA's preclinical studies demonstrate Ketamir-2's superior efficacy, safety, and optimized pharmacokinetics, supporting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results